Suchergebnisse - "Simpson, Eric L"

PubPharm (427)

1

Efficacy and safety of rademikibart (CBP-201), a next-generation mAb targeting IL-4Rα, in adults with moderate to severe atopic dermatitis : A phase 2 randomized trial (CBP-201-WW001)

enthalten in: The Journal of allergy and clinical immunology | 2024

von Silverberg, J. | Strober, B. | Feinstein, B. | +13

2

Evaluating the clinical utility of the Atopic Dermatitis Control Tool : measurement properties and agreement between patients' responses and clinicians' impressions of atopic dermatitis control

enthalten in: The British journal of dermatology | 2024

von Simpson, E. | Eckert, L. | Gadkari, A. | +9

3

Publisher Correction to : Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry

enthalten in: Dermatology and therapy | 2024

von Simpson, E. | Lockshin, B. | Lee, L. | +3

ErratumFor: Dermatol Ther (Heidelb). 2024 Jan;14(1):261-270. - PMID 38175364

4

Characterization of disease burden, treatment and comorbidities in a large, real-world cohort of patients with atopic dermatitis : The CorEvitas Atopic Dermatitis Registry

enthalten in: JAAD international | 2024

von Silverberg, J. | Cronin, A. | Jones, E. | +8

5

How to use the Harmonising Outcome Measures for Eczema Core Outcome Set for atopic dermatitis trials : a users' guide

enthalten in: The British journal of dermatology | 2024

von Thomas, K. | Howells, L. | Leshem, Y. | +8

CommentIn: Br J Dermatol. 2024 Jan 10;:. - PMID 38197422

6

The Social and Home Environment : Impacts of Determinants of Health on Atopic Dermatitis, Pathways Toward Solutions, and Unique Considerations for Rural and Remote North American Indigenous Populations

enthalten in: The journal of allergy and clinical immunology. In practice | 2024

von Asiniwasis, R. | Merati, N. | Roesler, J. | +8

7

Targeted Systemic Therapies for Adults with Atopic Dermatitis : Selecting from Biologics and JAK Inhibitors

enthalten in: American journal of clinical dermatology | 2024

von Kim, R. | Lam, M. | Abuabara, K. | +2

8

Summary of Research : An Anti-OX40 Antibody to Treat Moderate-to-Severe Atopic Dermatitis: A Multicentre, Double-Blind, Placebo-Controlled Phase 2b Study

enthalten in: Advances in therapy | 2024

von Guttman-Yassky, E. | Simpson, E. | Reich, K. | +7

9

Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adolescents and adults : pooled results from 2 phase 3 studies

enthalten in: The Journal of dermatological treatment | 2024

von Simpson, E. | Bissonnette, R. | Chiesa Fuxench, Z. | +4

10

Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis : Results from a phase 3, randomized, double-blind, placebo-controlled trial

enthalten in: Journal of the American Academy of Dermatology | 2024

von Simpson, E. | Silverberg, J. | Worm, M. | +14

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[43]